Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dexelvucitabine (RVT), a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 397.00 | |
25 mg | In stock | $ 663.00 | |
50 mg | In stock | $ 945.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 272.00 |
Description | Dexelvucitabine (RVT), a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection. |
Synonyms | D-D-4FC, DPC-817, RVT, beta-D-D-4FC, DFC |
Molecular Weight | 227.19 |
Formula | C9H10FN3O3 |
CAS No. | 134379-77-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/ml (132.05 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dexelvucitabine 134379-77-4 Microbiology/Virology Reverse Transcriptase D-D-4FC b-D-D-4FC Inhibitor thymidine DPC 817 Human immunodeficiency virus d-d4FC β-D-D-4FC cytidine DPC-817 DPC817 M184V mutation RVT antiretroviral inhibit Reverset 2′-deoxycytidine viral polymerase HIV resistant viruse nucleoside reverse transcriptase beta-D-D-4FC HIV-1 DFC inhibitor